Open drug databases compete for consumers

6 April 2008

Revolution Health, an on-line service offering health care and drug information to the US public, is offering a combination of expert content by trusted third parties and the personal experience of thousands of patients. Its new product, the Medicine Chest, carries medical and pharmacological data on 11,000 products for over 600 conditions at: www.revolutionhealth.com/drugs-treatments. A separate initiative (patientslikeme.com), is a social network for people to discuss experiences, good and bad, about their treatments which shares data with health care providers.

The adoption of Internet search engine technology to provide high-quality data to patients is creating a new avenue for getting information about prescription drugs. In doing so, the public is able to bypass traditional gate-keepers to pharmaceutical data, adding to both the opportunity and threat that self-medication offers, given the ready availability of some products on-line (Marketletters passim).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight